13.67
price up icon7.85%   0.995
pre-market  시장 영업 전:  13.44   -0.23   -1.68%
loading
전일 마감가:
$12.68
열려 있는:
$12.81
하루 거래량:
1.83M
Relative Volume:
1.70
시가총액:
$1.71B
수익:
$1.12B
순이익/손실:
$5.00M
주가수익비율:
1,367.00
EPS:
0.01
순현금흐름:
$-383.00M
1주 성능:
+13.54%
1개월 성능:
+14.11%
6개월 성능:
+20.33%
1년 성능:
-24.35%
1일 변동 폭
Value
$12.81
$13.77
1주일 범위
Value
$12.04
$13.77
52주 변동 폭
Value
$7.33
$18.05

Indivior Plc Stock (INDV) Company Profile

Name
명칭
Indivior Plc
Name
전화
804-379-1090
Name
주소
234 BATH ROAD, SLOUGH, BERKSHIRE
Name
직원
1,164
Name
트위터
Name
다음 수익 날짜
2024-10-24
Name
최신 SEC 제출 서류
Name
INDV's Discussions on Twitter

INDV을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
INDV
Indivior Plc
13.67 1.50B 1.12B 5.00M -383.00M 0.01
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.93 50.62B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
168.59 73.64B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.92 4.12M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 45.57B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.52 20.82B 16.54B -1.64B 749.00M -1.45

Indivior Plc Stock (INDV) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-28 개시 Rodman & Renshaw Buy
2024-07-23 개시 Piper Sandler Overweight
2024-04-03 개시 Craig Hallum Buy
2023-07-13 개시 Northland Capital Outperform

Indivior Plc 주식(INDV)의 최신 뉴스

pulisher
01:00 AM

Addex to Present Positive GABAB PAM Chronic Cough Data at the 10th American Cough Conference - GlobeNewswire Inc.

01:00 AM
pulisher
Jun 03, 2025

Indivior to delist from London Stock Exchange, maintain primary listing on Nasdaq - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Indivior PLC To Contact The Firm - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 02, 2025

Indivior’s exit comes as no surprise - The Times

Jun 02, 2025
pulisher
Jun 02, 2025

Levi & Korsinsky Notifies Indivior PLC Investors of a Class Action Lawsuit and Upcoming DeadlineINDV - ACCESS Newswire

Jun 02, 2025
pulisher
Jun 02, 2025

Opioid Use Disorder Market Projected to Witness Massive GrowthIndivior PLC, Alkermes plc - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Trending tickers: The latest investor updates on Tesla, Palantir, Sanofi, Babcock and Indivior - Yahoo

Jun 02, 2025
pulisher
Jun 02, 2025

Kalkine : Indivior’s Exit from London Exchange Impacts FTSE 100 Pharmaceutical Landscape - Kalkine Media

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to delist from London Stock Exchangewill stay on Nasdaq - Insider Media Ltd

Jun 02, 2025
pulisher
Jun 02, 2025

Drug maker Indivior joins London Stock Exchange exodus, 2 Jun 2025 11:00 - Shares Magazine

Jun 02, 2025
pulisher
Jun 02, 2025

Kalkine : Indivior’s FTSE 100 Sector Shift: Delisting from London to Focus on Nasdaq Listing - Kalkine Media

Jun 02, 2025
pulisher
Jun 02, 2025

Kalkine: Indivior Exits London as FTSE 100 Firm Focuses on Nasdaq - Kalkine Media

Jun 02, 2025
pulisher
Jun 02, 2025

FTSE pharma giant joins London stock market exodus - The Telegraph

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior (INDV) Delists from London to Focus on U.S. Market - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior brings curtain down on turbulent 11-year run in London - Proactive financial news

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior drops London listing to focus on U.S. market By Investing.com - Investing.com Nigeria

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior To Delist From LSE To Better Align With US Focused Business - Nasdaq

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to cancel secondary listing in London - Sharecast.com

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior Plans to Cancel London Listing After Moving Primary to US - Bloomberg

Jun 02, 2025
pulisher
Jun 02, 2025

Drug maker Indivior to abandon London stock market for the US - Yahoo

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to Cancel London Stock Exchange Listing, Focuses on Nasdaq - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to Cancel Secondary Listing on London Stock Exchange, Maintains Primary Nasdaq Listing | Indivior Stock News - paginasiete.bo

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior to delist from London Stock Exchange, maintain Nasdaq listing - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained | INDV Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Indivior Announces Intention to Cancel Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained - Bluefield Daily Telegraph

Jun 02, 2025
pulisher
Jun 01, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 1, 2024 in Indivior PLC LawsuitINDV - ACCESS Newswire

Jun 01, 2025
pulisher
May 27, 2025

Indivior Announces Patrick Barry as Chief Commercial Officer - The Malaysian Reserve

May 27, 2025
pulisher
May 27, 2025

Indivior appoints Patrick Barry as Chief Commercial Officer By Investing.com - Investing.com South Africa

May 27, 2025
pulisher
May 27, 2025

Indivior Announces Patrick Barry as Chief Commercial Officer | I - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Indivior appoints Patrick Barry as Chief Commercial Officer - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Indivior Announces Patrick Barry as Chief Commercial Officer | INDV Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Indivior PLC (INDV) Stock Analysis: A 30% Upside Potential Amidst Strong Buy Ratings - DirectorsTalk Interviews

May 27, 2025
pulisher
May 26, 2025

Investors in Indivior (LON:INDV) have seen solid returns of 156% over the past five years - Yahoo Finance

May 26, 2025
pulisher
May 23, 2025

How To Trade (INDV) - news.stocktradersdaily.com

May 23, 2025
pulisher
May 23, 2025

Indivior PLC (LON:INDV) Held Back By Insufficient Growth Even After Shares Climb 26% - simplywall.st

May 23, 2025
pulisher
May 21, 2025

Naloxone Market Projected To Witness Massive Growth, 2025-2032 - openPR.com

May 21, 2025
pulisher
May 16, 2025

Court of Appeal upholds representative action strike out in Wirral Council v Indivior/Reckitt, but claimant applies for permission to appeal to Supreme Court - stewartslaw.com

May 16, 2025
pulisher
May 15, 2025

Indivior PLC Aligns CEO Compensation with Long-Term Performance Goals - TipRanks

May 15, 2025
pulisher
May 14, 2025

Indivior to Participate in Upcoming Investor Events - StreetInsider

May 14, 2025
pulisher
May 13, 2025

Indivior to Participate in Upcoming Investor Events | INDV Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Indivior announces participation in investor conferences By Investing.com - Investing.com India

May 13, 2025
pulisher
May 13, 2025

Indivior to Engage with Investors at Key Healthcare Conferences - TipRanks

May 13, 2025
pulisher
May 13, 2025

Indivior to Participate in Upcoming Investor Events – Company Announcement - Financial Times

May 13, 2025
pulisher
May 13, 2025

Drug Addiction Treatment Market Projected To Witness Massive - openPR.com

May 13, 2025
pulisher
May 12, 2025

(INDV) Long Term Investment Analysis - news.stocktradersdaily.com

May 12, 2025
pulisher
May 12, 2025

Drug Abuse Treatment Market Grows Amid Rising Substance Abuse - openPR.com

May 12, 2025
pulisher
May 12, 2025

Indivior advances GABA-B PAM program for substance use disorders through IND-enabling studies - BioWorld MedTech

May 12, 2025
pulisher
May 12, 2025

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies - Yahoo

May 12, 2025
pulisher
May 10, 2025

Shareholders of Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your RightsINDV - ACCESS Newswire

May 10, 2025

Indivior Plc (INDV) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$8.59
price down icon 1.38%
drug_manufacturers_specialty_generic RDY
$14.75
price up icon 0.61%
$124.52
price down icon 0.38%
drug_manufacturers_specialty_generic HCM
$15.30
price up icon 4.08%
$323.97
price down icon 0.07%
$17.52
price up icon 1.92%
자본화:     |  볼륨(24시간):